Inferior Vena Caval Syndrom in Paraaortic Metastastic Lession of Ovarian Dysgerminoma in Pregnancy Manage with Chemotherapy : a Case Report

Authors

  • Madona Utami Dewi Resident of Obstetrics and Gynecology, Faculty of Medicine, Andalas University, Dr. M. Djamil Central General Hospital Padang
  • Syamel Muhammad Sub Division of Gynecological Oncology, Obstetrics and Gynecology Department, Faculty of Medicine, Andalas University, Dr. M. Djamil Central General Hospital Padang

DOI:

https://doi.org/10.25077/aoj.3.1.46-63.2019

Abstract

Background : Inferior caval syndrom is a rare case. It can caused by compresssion of the tumor mass and paraaortic metastastasis lession of ovarian dysgerminoma. Dysgerminoma is one of the most common germ cell tumor, approximately 3-5% of all ovarian cancers.1 Rate of dysgerminoma metastasis to lymph node is around 28%. In all type of germ cell, dysgerminoma has higher insidens to lymph node metastasis compare to the others. The first level of lymph node metastsis is paraaortic lymph node. However, the insidens is unknown because there is no research about it yet.2,3 Dysgerminoma frequently in young age, less then 30 years. The exact etiology of dysgerminomas has not been determined, although recent molecular studies have implicated loss function of potential tumor suppressor gene TRC8/RNF139, abnormality of Y chromosome and gonadal dysgenesis.4 The problem arises when dysgerminoma is diagnosed in pregnancy woman as clinically has inferior vena cava syndrom sign and symptoms which acquired efective and fast management.

Objective : Discuss inferior caval syndrom as effect of compression by tumor mass, metastasis tumor lesion and chemotherapy management in dysgerminoma with pregnancy

Case Report : Patient 32 years old admitted to M. Djamil central general hospital referred from Batusangkar hospital with diagnosis G3P2A0L2 25-26 weeks of preterm pregnancy + dysgerminoma + obs. Dyspnue. Patient has symptoms dispnue, exercise intolerance, oedem extremity. Physical examination : blood pressure was 100/70 mmHg, HR 120 dpm, RR 35 bpm, T 37 C. Abdomen : uterus fundal was palpated 2 fingers above umbilical, ballotement (+), FHR 150-158 bpm. Genitalia : I V/U normal, vaginal bleeding (-), oedem extremity +/+. From ultrasonography found dysgerminoma ovary with compression to inferior vena cava and paraaortic metastatic. Patient was diagnosed with dispnue ec. inferior vena cava syndrom caused by compression of tumor mass + paraaortic lymph node metastasis lession of ovarian dysgerminoma on G3P2A0L2 25-26 weeks of preterm pregnancy. Patient was managed by BEP chemotherapy and symptom was dissapeared. Patient was admitted to M. Djamil again with 34-35 weeks of preterm pregnancy in active phase of first stage. Because obtructed of labor patient was decide to performed LSCS. Female baby was born 1800 gram, baby’s length was 45 cm, A/S 7/8, there is no congenital anomaly. Patient was followed up 1 month after surgery, there is no symptoms, but fromUltrasonograhy found corpus metastasis and CT scan impressed paraaortic lymph node metastasis + copus metastasis. Chemotherapy was continue one month after caesarean section. She was completed 4 cycles chemothrapy and the disease was cureable.

Conclusion : Caval syndrom is a rare case and fatal, caused by direct compression of dysgerminoma mass and paraaortic lymph node metastasis. Diagnosis of dysgerminoma is anatomy pathology diagnose. Management of dysgerminoma is surgical staging and 3-4 cycle of chemoterapy with BEP regimen. Chemoterapy with BEP (Bleomisin-Etopuside-Cisplatin) is safe to performed at second trimester with inferior vena cava syndrom ec paraaorta lymph nodes metastasis.          Dysgerminoma has a good response to chemotherapy with survival rate 96%

Keywords: Caval syndrom, lymph node paraaortic metastatic

References

Marc Gewilig. Obstructions of the Inferior and Superior Vena Cava. VOWB, Belgium: p.669-73

Masayuki Takemori, Takaya Ichimura, Ryuichiro Nishimura, Kazuo Hasegawa. Ovaria Dysgerminoma with Massive Metastases to Paraaortic Lymph Nodes.2000. Gynecol Obstet Invest: 49: 211-13

Victor E Valdespino, Yazzmin Ballesteros, Montenegro, Maricruz Rivera Hernandjez, German Maytorena Cordova, Juan Landa Mejia, dkk. 2 Cases Dysgerminoma with Micrometastases in Lymph Nodes. 2018. Medcrave: Obstet Gynecol Int: 10(I) p.31-4

Chad M Michener. Editor: Warner K Huh. Ovarian Dysgerminomas. 2018. Medscape. Diakses tanggal 14 Februari 2019

Satoshi Tamauchi, Hiroaki Kijiyama, Masato Yoshihara, Yoshiki Ikeda, Nobuhisa Yoshikawa, Kimihiro Nishihino, dkk. Reproductive Outcomes of 105 Malignant Ovarian Germ Cell Tumor Survivors: a Multicenter Study. 2018. AJOG: p.385 e1-e7

William D. Tucker, Bracken Burns. Anatomy Abdomen Pelvis, Inferior Vena Cava. 2018. StatPearls Publishing:NCBI

Jonathan S Berek, Michael L Driedlander, Nevile F Hacker. Germ Cell and Nonepithelial Ovarian Cancer in Berek & Hecker Gynecology Oncology Text Book.2015. Baltimore : Walters Kluwer : Chap.12 p. 530

Shinichi Komiyama. Safe dissection of High Paraaortic Lymph Nodes Superior to the Renal Vein in Ovarian, Primary Peritoneal, or Fallopian Tube Cancer by the “ Komiyama’s Maneuverâ€, a Modification of Kocher’s Maneuver.2017. ScienceDirect Elsevier.Vol.145: p.407-8 https://doi.org/10.1016/j.ygyno.2017.02. 015

Osman Turkmen, Alper Karalok, Derman Basaran, Gunsu Comert Kimyon, Tolga Tasci, Isin Ureyen, dkk. Fertility- Sparing Surgery Should be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors. 2017. Journl of Adolescent and Young Adult Oncology. Vol: 00. Doi:10.1089/jayao.2016.0086

Mamta Gupta, Vandana Saini. Germ Cell Tumors and their Association with Pregnancy. 2018. INTECH:Chap 6: p. 12341.doi.org/10.5772/intechopen.7255 6

Michael Hubalek, Caecilia Smekal, Alan G Zeimet, Consolato Sergi, Christoph Brezinka, Elisabeth Mueller, dkk. Chemotherapeuitic of a Pregnant Patient with Ovarian Dysgerminoma. 2007. Arch Gynecol Obstet. 276: 179- 183 DOI 10.1007/s00404-007-0328-2

Bender F Aldhafery. Ovarian Dysgerminoma in Two Sister. 2008. J Family Community. Med. 2008 Sep- Dec; 15(3): 127–131.

Tamara L Callahan, Aaron B Caughey. Ovarian & Fallopian Tube Tumor in Obstetric & Gynecology Textbook. 2018. Philadelpia: Walters Kluwer; Chap 30 p.1026-41

Ting Zhao, Yan Liu, Hongyuan Jiang, Hao Zhang aand Yuan lu. Management of Bilateral Malignant Ovararian Germ Cell Tumors: Experience of a single Institute. 2015. Molecular and Clinicak Oncology 5: 383-7

Jasmina Popovic, Sonja Trajkovic, Milan Trenkic, Aleksandra Aracki. Dysgerminoma and Pregnancy. 2017. DOI https://doi.org/10.2298/SARH16092307 4

I Nyoman, I Wayan Artana. Kehamilan dengan Kanker Ovarium Tipe Disgerminoa Stadium 1C. 2016. Universitas Udayana

Jana Dekrem, Kristel Van Calsteren. Efect of Fetal Exposureto Maternal Chemotherapy. 2013. Springer Inernational Publishing Switzerland. Doi 10.1007/s40272-013-0040-6

Yuanyuan Chen, Ying Luo, Cha Han, Wenyan Tian, Wen Yang, Yiengmei Wan,dkk. Ovarian Dysgerminoma in Pregnancy: a Case report and Literature Review. 2018. Jounal Cancer Biology &Therapy.doi.org/10.1080/15384047.2 018.1450118

Mamta Gupta, Rita Jindal, Vandana Saini. An Incidental Finding of Bilateral Dysgerminoma During Caesarean Section: Dilemmas in Management. 2016.DOI:10.7860/JCDR/2016/20163.8 319

Yoon Kyung Lee, Chang Young Yoo, Guisera Lee, Dong Choon Park. Ovarian Dysgerminoma Associated with Pregnancy. 2011. Korean J Obest Gynecol 2011; 54(4);218-222 doi.10.5468/KJOG.2011.54.4.218

Nexhmi Hyseni, Sadik Llullaku, Hysni Jashari, Kaltrina Zhiti, Fjolla Hyseni, Fisnik Kurshumliu, dkk. Advanced Ovarian Dysgerminoma Infiltrating Both Ovaries and Uterus in a 7-year-old Girl. 2014. Hindawi: vol. 2014, Articel ID910852.Doi.0rg/10.1155/2014/91085 2

Ivani Juliarty Sitanggang. Dysgerminoma Ovarium pada anak perempuan 16 tahun. Denpasar.

Kafil Akhtar, Shamshad Ahmad, Amit Kumar, Noor Afshan. Dysgerminoma with Pregnancy and Viable Baby: A Case Report. 2011. Oman Medical Journal Vol.26 No.3 : 198-200

Downloads

Published

2020-09-11

Issue

Section

CASE REPORT